Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-2.44%||68.93||1.0%||$497.91m|
|REGN||Regeneron Pharmaceuticals, Inc.||-2.73%||636.53||2.7%||$490.45m|
|VRTX||Vertex Pharmaceuticals, Inc.||-1.67%||186.94||1.9%||$375.32m|
|SNSS||Sunesis Pharmaceuticals, Inc.||0.88%||4.61||0.7%||$322.26m|
|EXAS||EXACT Sciences Corp.||-1.39%||85.37||18.0%||$167.68m|
|BMRN||BioMarin Pharmaceutical, Inc.||-1.27%||86.29||4.2%||$144.64m|
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.